Literature DB >> 10639352

Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system.

L Zhang1, X Z Li, K Poole.   

Abstract

Clinical strains of Stenotrophomonas maltophilia are often highly resistant to multiple antibiotics, although the mechanisms of resistance are generally poorly understood. Multidrug resistant (MDR) strains were readily selected by plating a sensitive reference strain of the organism individually onto a variety of antibiotics, including tetracycline, chloramphenicol, ciprofloxacin, and norfloxacin. Tetracycline-selected MDR strains typically showed cross-resistance to erythromycin and fluoroquinolones and, in some instances, aminoglycosides. MDR mutants selected with the other agents generally displayed resistance to chloramphenicol and fluoroquinolones only, although two MDR strains (e.g., K1385) were also resistant to erythromycin and hypersusceptible to aminoglycosides. Many of the MDR strains expressed either moderate or high levels of a novel outer membrane protein (OMP) of ca. 50 kDa molecular mass, a phenotype typical of MDR strains of Pseudomonas aeruginosa hyperexpressing drug efflux systems. Indeed, the 50-kDa OMP of these S. maltophilia MDR strains reacted with antibody to OprM, the outer membrane component of the MexAB-OprM MDR efflux system of P. aeruginosa. Similarly, a ca. 110-kDa cytoplasmic membrane protein of these MDR strains also reacted with antibody to the MexB component of the P. aeruginosa pump. The outer and cytoplasmic membranes of several clinical S. maltophilia strains also reacted with the anti-OprM and anti-MexB antibodies. N-terminal amino acid sequencing of a cyanogen bromide-generated peptide of the 50-kDa OMP of MDR strain K1385, dubbed SmeM (Stenotrophomonas multidrug efflux), revealed it to be very similar to a number of outer membrane multidrug efflux components of P. aeruginosa and Pseudomonas putida. Deletion of the L1 and L2 beta-lactamase genes confirmed that these enzymes were responsible for the bulk of the beta-lactam resistance of K1385 and its parent. Still, overexpression of the MDR efflux mechanism in an L1- and L2-deficient derivative of K1385 did yield a modest increase in resistance to a few beta-lactams. These data are consistent with the MDR efflux mechanism(s) playing a role in the multidrug resistance of S. maltophilia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639352      PMCID: PMC89673          DOI: 10.1128/AAC.44.2.287-293.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  44 in total

1.  Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa.

Authors:  T Köhler; M Michéa-Hamzehpour; U Henze; N Gotoh; L K Curty; J C Pechère
Journal:  Mol Microbiol       Date:  1997-01       Impact factor: 3.501

2.  Overexpression, purification, and characterization of the cloned metallo-beta-lactamase L1 from Stenotrophomonas maltophilia.

Authors:  M W Crowder; T R Walsh; L Banovic; M Pettit; J Spencer
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

3.  Molecular heterogeneity of the L-1 metallo-beta-lactamase family from Stenotrophomonas maltophilia.

Authors:  F Sanschagrin; J Dufresne; R C Levesque
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

4.  Beta-lactamase inhibitors are substrates for the multidrug efflux pumps of Pseudomonas aeruginosa.

Authors:  X Z Li; L Zhang; R Srikumar; K Poole
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

5.  Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case controlled study.

Authors:  V Krcméry; S Spanik; I Krupova; J Trupl; A Kunova; M Smid; E Pichnova
Journal:  J Chemother       Date:  1998-08       Impact factor: 1.714

6.  Multidrug efflux pump AcrAB of Salmonella typhimurium excretes only those beta-lactam antibiotics containing lipophilic side chains.

Authors:  H Nikaido; M Basina; V Nguyen; E Y Rosenberg
Journal:  J Bacteriol       Date:  1998-09       Impact factor: 3.490

7.  An overview of the kinetic parameters of class B beta-lactamases.

Authors:  A Felici; G Amicosante; A Oratore; R Strom; P Ledent; B Joris; L Fanuel; J M Frère
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

8.  Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples.

Authors:  M Denton; N J Todd; K G Kerr; P M Hawkey; J M Littlewood
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

9.  A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants.

Authors:  T T Hoang; R R Karkhoff-Schweizer; A J Kutchma; H P Schweizer
Journal:  Gene       Date:  1998-05-28       Impact factor: 3.688

10.  Contribution of outer membrane efflux protein OprM to antibiotic resistance in Pseudomonas aeruginosa independent of MexAB.

Authors:  Q Zhao; X Z Li; R Srikumar; K Poole
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

View more
  51 in total

1.  Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains.

Authors:  S Valdezate; A Vindel; E Loza; F Baquero; R Cantón
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  Stenotrophomonas maltophilia D457R contains a cluster of genes from gram-positive bacteria involved in antibiotic and heavy metal resistance.

Authors:  A Alonso; P Sanchez; J L Martínez
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

3.  Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia.

Authors:  A Alonso; J L Martinez
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 4.  Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria.

Authors:  K Poole
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

5.  Induction of L1 and L2 beta-lactamases of Stenotrophomonas maltophilia.

Authors:  Rouh-Mei Hu; Kuang-Jay Huang; Lii-Tzu Wu; Ying-Ju Hsiao; Tsuey-Ching Yang
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

6.  Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia Infections.

Authors:  Cara Nys; Kartik Cherabuddi; Veena Venugopalan; Kenneth P Klinker
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

7.  Clinical Features, Antibiotic Susceptibility Profile, and Outcomes of Infectious Keratitis Caused by Stenotrophomonas maltophilia.

Authors:  Sotiria Palioura; Allister Gibbons; Darlene Miller; Terrence P OʼBrien; Eduardo C Alfonso; Oriel Spierer
Journal:  Cornea       Date:  2018-03       Impact factor: 2.651

8.  Involvement of a novel efflux system in biofilm-specific resistance to antibiotics.

Authors:  Li Zhang; Thien-Fah Mah
Journal:  J Bacteriol       Date:  2008-05-09       Impact factor: 3.490

Review 9.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

10.  Optimizing fluoroquinolone utilization in a public hospital: a prospective study of educational intervention.

Authors:  K Lacombe; S Cariou; P Tilleul; G Offenstadt; J L Meynard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-01       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.